- Home
- PFN vs CRON Comparison
PFN vs CRON Comparison
Compare PFN & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFN
- CRON
- Stock Information
- Founded
- PFN 2004
- CRON 2012
- Country
- PFN United States
- CRON Canada
- Employees
- PFN N/A
- CRON N/A
- Industry
- PFN Finance/Investors Services
- CRON Medicinal Chemicals and Botanical Products
- Sector
- PFN Finance
- CRON Health Care
- Exchange
- PFN Nasdaq
- CRON Nasdaq
- Market Cap
- PFN 663.1M
- CRON 707.7M
- IPO Year
- PFN N/A
- CRON N/A
- Fundamental
- Price
- PFN $7.54
- CRON $1.81
- Analyst Decision
- PFN
- CRON Hold
- Analyst Count
- PFN 0
- CRON 2
- Target Price
- PFN N/A
- CRON $3.00
- AVG Volume (30 Days)
- PFN 331.7K
- CRON 1.4M
- Earning Date
- PFN 01-01-0001
- CRON 05-08-2025
- Dividend Yield
- PFN 11.66%
- CRON N/A
- EPS Growth
- PFN N/A
- CRON N/A
- EPS
- PFN N/A
- CRON 0.11
- Revenue
- PFN N/A
- CRON $117,615,000.00
- Revenue This Year
- PFN N/A
- CRON $22.27
- Revenue Next Year
- PFN N/A
- CRON $7.36
- P/E Ratio
- PFN N/A
- CRON $16.68
- Revenue Growth
- PFN N/A
- CRON 34.82
- 52 Week Low
- PFN $5.94
- CRON $1.77
- 52 Week High
- PFN $7.58
- CRON $3.14
- Technical
- Relative Strength Index (RSI)
- PFN 51.02
- CRON 41.93
- Support Level
- PFN $7.51
- CRON $1.78
- Resistance Level
- PFN $7.57
- CRON $1.84
- Average True Range (ATR)
- PFN 0.04
- CRON 0.06
- MACD
- PFN 0.00
- CRON -0.01
- Stochastic Oscillator
- PFN 76.81
- CRON 38.64
About PFN PIMCO Income Strategy Fund II
PIMCO Income Strategy Fund II is a closed-ended fixed income mutual fund. The company's primary investment objective is to seek high current income, consistent with the preservation of capital. The fund invests in a range of securities, such as corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, municipal bonds and notes, short-term instruments, sovereign Issues, preferred Securities and others.
About CRON Cronos Group Inc. Common Share
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.